ArticlePsoriasis (Auckland, N.Z.)2025

PEGylated Peptide for Targeted Inhibition of Human Antigen R as a Novel Therapeutic Strategy for Psoriasis: A Proof-of-Concept Study.

Yu-Fon Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.